Recent News

• 06.03.2025 - Personalis’ NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO
• 06.03.2025 - Personalis’ NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO
• 06.02.2025 - New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse
• 06.02.2025 - New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse
• 06.02.2025 - Subbu Nambi
• 06.02.2025 - Subbu Nambi
• 05.22.2025 - Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection
• 05.22.2025 - Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection
• 05.14.2025 - Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference
• 05.14.2025 - Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference

Recent Filings

• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 8-K Current report